Free tool
Healthcare stocks
We cover 1,285 companies in the Healthcare sector. The median market value in the group is $2.15B, measured across the 1,000 largest of them. Among those 1,000, the median move over the past trading day is 0.00%. 66% of the 964 with a 200-day average trade above it. Price change over the past year runs from −30.1% to +165.8% across the middle 80 percent of the group, with a median of +17.2%. Among those 1,000, 8 companies currently carry a tier A volume signal.
Other lists in this group
Table
1,285 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| HCM | HUTCHMED (China) Limited | $12.35 | +10.27% | −9.52% | −17.45% |
| STOK | Stoke Therapeutics, Inc. | $33.09 | +12.59% | +7.09% | +71.45% |
| GN.CO | GN Store Nord A/S | 94.54 DKK | −2.03% | −13.98% | −18.50% |
| XNCR | Xencor, Inc. Common Stock | $28.44 | +42.41% | +90.62% | +254.61% |
| 008930.KS | Hanmi Science Co., Ltd. | 43,400.00 KRW | +29.36% | +19.84% | +2.80% |
| ZYME | Zymeworks Inc. | $29.31 | +29.61% | +10.09% | +96.28% |
| NVCR | NovoCure Limited | $17.89 | +9.69% | +36.36% | +50.21% |
| ALIF-B.ST | AddLife AB (publ) | 162.30 SEK | +0.87% | +8.17% | −7.20% |
| GNS.L | Genus plc | 2,298.00 GBP | +3.23% | −9.70% | −12.94% |
| GENB | Generate Biomedicines, Inc. | $16.14 | +22.83% | +27.59% | +27.59% |
| SRPT | Sarepta Therapeutics, Inc. | $19.46 | +26.12% | −8.68% | +7.69% |
| NANO.PA | Nanobiotix S.A. | 35.74 EUR | +8.43% | +88.11% | +358.21% |
| PRGO | Perrigo Company plc | $14.76 | +43.30% | +8.65% | −36.05% |
| SEM | Select Medical Holdings Corp | $16.51 | −0.12% | +12.30% | +28.14% |
| AGIO | Agios Pharmaceuticals, Inc. Common Stock | $33.99 | −5.56% | +25.06% | −13.45% |
| CMPS | COMPASS Pathways plc | $14.61 | +34.65% | +123.05% | +209.53% |
| 6960.T | Fukuda Denshi Co., Ltd. | 11,970.00 JPY | +5.37% | +57.28% | +79.12% |
| GHRS | GH Research PLC | $29.01 | +3.76% | +119.11% | +112.84% |
| VIMIAN.ST | Vimian Group AB (publ) | 35.35 SEK | +1.58% | +15.22% | +12.01% |
| PIII | P3 Health Partners Inc. | $9.92 | −5.70% | +183.43% | +26.37% |
| PGNY | Progyny, Inc. | $26.37 | −14.27% | +2.45% | +14.55% |
| S1RP34.SA | Sarepta Therapeutics, Inc. | 4.82 BRL | +24.55% | −17.18% | −12.20% |
| FLRY3.SA | Fleury S.A. | 18.66 BRL | +9.38% | +25.83% | +37.82% |
| TSHA | Taysha Gene Therapies, Inc. | $6.02 | +10.26% | +14.67% | +102.69% |
| EMBLA.CO | Embla Medical hf. | 30.15 DKK | +5.05% | −5.78% | −6.94% |
| GXE.DE | Lakefront Biotherapeutics NV | 24.68 EUR | +0.82% | −12.36% | −44.50% |
| IMCR | Immunocore Holdings plc | $37.12 | +10.77% | +9.89% | +13.69% |
| ASTH | Astrana Health, Inc. | $38.61 | +1.69% | +53.09% | +23.71% |
| LKFT | Lakefront Biotherapeutics NV | $29.16 | +3.59% | −11.56% | −11.39% |
| SNDA | Sonida Senior Living, Inc. | $39.67 | −7.89% | +24.24% | +51.53% |
| NTLA | Intellia Therapeutics, Inc. | $13.19 | +21.12% | +43.21% | +15.50% |
| DMRA | Damora Therapeutics, Inc. | $30.39 | +3.30% | +39.28% | +804.46% |
| SEPN | Septerna, Inc. | $40.25 | +18.49% | +43.85% | +218.81% |
| NEU.AX | Neuren Pharmaceuticals Limited | 20.59 AUD | +20.20% | +8.88% | +5.54% |
| VIR | Vir Biotechnology, Inc. | $11.08 | +25.20% | +86.53% | +111.85% |
| RXRX | Recursion Pharmaceuticals, Inc. | $3.49 | +14.43% | −16.90% | −28.63% |
| DRW8.DE | Drägerwerk AG & Co. KGaA | 82.40 EUR | +8.42% | +52.87% | +53.42% |
| SGRY | Surgery Partners, Inc. | $14.04 | −9.88% | −7.99% | −38.48% |
| PSNL | Personalis, Inc. | $17.08 | +43.77% | +117.58% | +257.32% |
| BLFS | BioLife Solutions, Inc. | $37.00 | +15.70% | +54.88% | +45.50% |
| INBX | Inhibrx Biosciences, Inc. | $125.34 | +57.30% | +67.03% | +357.45% |
| LMAT | LeMaitre Vascular, Inc. | $79.61 | −22.18% | −0.22% | −16.20% |
| 4540.T | Tsumura & Co. | 3,828.00 JPY | −5.36% | −5.27% | +10.98% |
| ETON | Eton Pharmaceuticals, Inc. | $62.62 | +34.20% | +285.12% | +262.38% |
| INSP | Inspire Medical Systems, Inc. | $61.80 | +18.91% | −33.02% | −33.04% |
| ATT.ST | Attendo AB (publ) | 117.90 SEK | +7.57% | +49.22% | +80.74% |
| SNDX | Syndax Pharmaceuticals, Inc. | $20.09 | +2.34% | −5.68% | +23.55% |
| FTRE | Fortrea Holdings Inc. | $18.53 | −10.48% | +10.23% | +105.20% |
| ALVO | Alvotech | $4.91 | +58.39% | −1.80% | −38.85% |
| ALVO-SDB.ST | Alvotech | 46.45 SEK | +33.67% | +1.57% | −39.57% |
| ANAB | AnaptysBio, Inc. | $58.00 | +11.30% | +93.55% | +326.47% |
| ANIP | ANI Pharmaceuticals, Inc. | $74.56 | −8.00% | −4.93% | −18.85% |
| MAZE | Maze Therapeutics, Inc. | $29.58 | +6.10% | −25.62% | +113.27% |
| CLARI.PA | Clariane SE | 4.01 EUR | −0.89% | +2.14% | −6.95% |
| SIA.TO | Sienna Senior Living Inc. | 21.63 CAD | −6.89% | +7.73% | +25.96% |
| 7716.T | Nakanishi Inc. | 3,155.00 JPY | +5.94% | +58.15% | +52.27% |
| AVLN | Avalyn Pharma Inc. | $37.04 | +33.29% | +25.60% | +25.60% |
| BCAX | Bicara Therapeutics Inc. | $24.73 | −8.00% | +50.98% | +105.74% |
| FBRX | Forte Biosciences, Inc. | $76.99 | +0.44% | +226.09% | +589.87% |
| 8129.T | Toho Holdings Co., Ltd. | 3,927.00 JPY | −9.06% | −14.11% | −24.33% |
| AGL | agilon health, inc. | $95.74 | −3.43% | +468.19% | +194.58% |
| PYC.AX | PYC Therapeutics Limited | 2.25 AUD | +38.46% | +35.95% | +74.42% |
| 4DX.AX | 4DMedical Limited | 3.70 AUD | +13.34% | −18.61% | +669.79% |
| ARDT | Ardent Health, Inc. | $11.23 | −2.09% | +29.98% | −11.64% |
| XERS | Xeris Biopharma Holdings, Inc. | $8.68 | +5.34% | +18.10% | +8.64% |
| ABSI | Absci Corporation | $9.22 | +29.31% | +155.40% | +261.57% |
| TRAX | First Tracks Biotherapeutics, Inc. | $44.19 | +5.59% | +132.58% | +132.58% |
| AAPG | Ascentage Pharma Group Internat | $16.90 | −7.57% | −35.91% | −59.18% |
| A2RR34.SA | Arrowhead Pharmaceuticals, Inc. | 57.60 BRL | +8.15% | +25.08% | +298.89% |
| HCSG | Healthcare Services Group, Inc. | $22.91 | −3.54% | +32.05% | +47.05% |
| 8086.T | Nipro Corporation | 1,535.50 JPY | −8.00% | +4.31% | +4.28% |
| BONEX.ST | Bonesupport Holding AB (publ) | 224.40 SEK | +1.54% | +26.07% | −28.26% |
| TYRA | Tyra Biosciences, Inc. | $26.22 | −15.09% | −2.13% | +103.57% |
| KMTS | Kestra Medical Technologies, Ltd. | $26.57 | +11.36% | +8.94% | +47.61% |
| LBRX | LB Pharmaceuticals Inc | $48.17 | +37.85% | +135.64% | +178.41% |
| DIA.WA | Diagnostyka S.A. | 167.60 PLN | +0.72% | −3.07% | −17.76% |
| AVBP | ArriVent BioPharma, Inc. | $31.14 | +3.87% | +49.71% | +62.10% |
| CNMD | CONMED Corporation | $50.48 | +14.08% | +24.58% | −6.91% |
| INVA | Innoviva, Inc. | $21.24 | −2.61% | +6.89% | +7.06% |
| OMCL | Omnicell, Inc. | $33.45 | −22.30% | −25.90% | +0.66% |
| 4516.T | Nippon Shinyaku Co., Ltd. | 3,588.00 JPY | +1.07% | −34.41% | +19.48% |
| NVAX | Novavax, Inc. | $9.21 | +24.97% | +29.17% | +21.50% |
| NOLA-B.ST | Nolato AB (publ) | 51.80 SEK | +6.91% | −10.27% | −7.00% |
| 6849.T | Nihon Kohden Corporation | 1,491.00 JPY | −10.13% | −11.05% | −7.26% |
| REPL | Replimune Group, Inc. | $15.88 | +196.82% | +78.43% | +187.16% |
| SPTX | Seaport Therapeutics, Inc. | $27.84 | +39.90% | +40.32% | +40.32% |
| TNDM | Tandem Diabetes Care, Inc. Common Stock | $21.37 | +20.33% | −0.84% | +74.45% |
| RDC.DE | Redcare Pharmacy NV | 62.05 EUR | −10.46% | −6.06% | −23.82% |
| INNV | InnovAge Holding Corp. | $11.04 | −6.52% | +112.72% | +178.79% |
| CGEM | Cullinan Therapeutics, Inc. | $22.85 | +30.80% | +125.79% | +188.15% |
| AKTS | Aktis Oncology, Inc. | $26.51 | +15.41% | +18.35% | +18.35% |
| AZTA | Azenta, Inc. | $33.57 | +16.04% | +0.54% | +11.16% |
| OMDA | Omada Health, Inc. | $23.96 | +17.28% | +60.81% | +2.74% |
| PAHC | Phibro Animal Health Corporation | $36.09 | −0.77% | −3.02% | +13.01% |
| SDGR | Schrödinger, Inc. | $19.47 | +27.34% | +8.29% | −1.62% |
| ENOV | Enovis Corporation | $25.25 | −14.46% | −4.75% | −18.60% |
| AMBEA.ST | Ambea AB (publ) | 173.60 SEK | +21.74% | +27.37% | +38.66% |
| ATEC | Alphatec Holdings, Inc. | $9.42 | +1.07% | −54.62% | −41.78% |
| ORIC | ORIC Pharmaceuticals, Inc. | $13.91 | +16.79% | +70.26% | +35.58% |
| KALV | KalVista Pharmaceuticals Inc | $27.00 | 0.00% | +74.64% | +98.68% |
| ANRO | Alto Neuroscience, Inc. | $36.53 | +33.22% | +120.19% | +786.65% |
| MGTX | MeiraGTx Holdings plc | $14.92 | +26.23% | +91.04% | +100.54% |
| 4483.T | JMDC Inc. | 3,440.00 JPY | +5.52% | −11.43% | −17.21% |
| GDS.PA | Ramsay Générale de Santé SA | 10.95 EUR | −0.45% | +17.24% | +9.50% |
| IMTX | Immatics N.V. | $9.43 | +7.96% | −9.76% | +74.63% |
| OMER | Omeros Corporation | $18.22 | +61.52% | +11.23% | +328.71% |
| JBIO | Jade Biosciences, Inc. | $21.33 | +8.27% | +50.64% | +168.30% |
| F9L.F | Joincare Pharmaceutical Group Industry Co.,Ltd. | 6.50 EUR | −2.99% | −48.41% | −48.41% |
| DRTS | Alpha Tau Medical Ltd. | $14.96 | +29.52% | +209.73% | +343.92% |
| 3148.T | Create SD Holdings Co., Ltd. | 3,410.00 JPY | −3.26% | +3.54% | +1.90% |
| 9627.T | Ain Holdings Inc. | 6,142.00 JPY | −2.57% | −5.73% | +2.85% |
| P1RG34.SA | Perrigo Company plc | 50.71 BRL | −1.59% | −31.71% | −59.77% |
| VITR.ST | Vitrolife AB (publ) | 95.10 SEK | +9.31% | −27.76% | −30.23% |
| 3360.T | Ship Healthcare Holdings, Inc. | 2,350.00 JPY | −8.38% | −8.58% | +8.25% |
| NUTX | Nutex Health Inc. | $195.92 | +31.46% | +32.21% | +118.22% |
| PNTG | The Pennant Group, Inc. | $38.28 | −8.90% | +37.55% | +56.31% |
| CHEMM.CO | ChemoMetec A/S | 496.80 DKK | +15.59% | −26.35% | −3.94% |
| UPR.L | Uniphar plc | 370.00 GBP | −1.33% | +23.75% | +6.94% |
| AORT | Artivion, Inc. | $27.20 | +0.70% | −38.82% | −37.81% |
| AMN | AMN Healthcare Services, Inc. | $34.24 | −1.30% | +126.46% | +70.26% |
| MLTX | MoonLake Immunotherapeutics | $15.62 | −16.52% | +30.71% | −71.82% |
| REG.AX | Regis Healthcare Limited | 6.09 AUD | −4.09% | −11.19% | −20.05% |
| MNKD | MannKind Corporation | $4.09 | +4.60% | −26.96% | −9.51% |
| CRON.TO | Cronos Group Inc. | 4.95 CAD | +23.75% | +34.15% | +39.83% |
| CRON | Cronos Group Inc. | $3.55 | +24.56% | +31.48% | +38.67% |
| IART | Integra LifeSciences Holdings Corporation | $16.88 | −14.57% | +40.55% | +13.52% |
| VOR | Vor Biopharma Inc. | $23.67 | +18.35% | +103.35% | −40.82% |
| SPI.L | Spire Healthcare Group plc | 237.00 GBP | +1.28% | +40.25% | +7.25% |
| RYM.AX | RYM FPO NZX [RYM] | 1.74 AUD | −8.42% | −32.30% | −27.80% |
| 4544.T | H.U. Group Holdings, Inc. | 3,634.00 JPY | +1.08% | +8.30% | +2.77% |
| SANA | Sana Biotechnology, Inc. | $4.16 | +26.44% | −0.72% | +23.44% |
| GDRX | GoodRx Holdings, Inc. | $3.65 | +16.99% | +32.73% | −18.89% |
| CERT | Certara, Inc. | $8.22 | +3.92% | −5.95% | −25.07% |
| 2175.T | SMS Co., Ltd. | 2,391.00 JPY | +0.80% | +80.27% | +54.71% |
| ODTX | Odyssey Therapeutics, Inc. | $25.62 | +39.01% | +56.03% | +56.03% |
| GLUE | Monte Rosa Therapeutics, Inc. | $14.38 | −34.75% | −6.07% | +207.92% |
| BIOG-B.ST | BioGaia AB (publ) | 117.10 SEK | +1.39% | +15.05% | +13.96% |
| CRVS | Corvus Pharmaceuticals, Inc. | $14.73 | +10.67% | +101.23% | +167.82% |
| SNZ.AX | Summerset Group Holdings Limited | 7.00 AUD | −0.14% | −32.73% | −26.63% |
| 4553.T | Towa Pharmaceutical Co., Ltd. | 3,915.00 JPY | −7.56% | +9.34% | +34.65% |
| 6523.T | PHC Holdings Corporation | 1,527.00 JPY | +36.71% | +37.93% | +58.42% |
| PRCT | PROCEPT BioRobotics Corporation | $21.07 | +16.54% | −31.50% | −48.36% |
| CVSG.L | CVS Group plc | 1,296.00 GBP | +3.27% | +1.73% | +2.05% |
| 4887.T | Sawai Group Holdings Co., Ltd. | 1,607.50 JPY | −6.02% | −31.23% | −12.86% |
| AVNS | Avanos Medical Inc | $24.99 | +0.04% | +123.52% | +110.53% |
| USPH | U.S. Physical Therapy, Inc. | $78.27 | −0.92% | +0.55% | −5.67% |
| KURA | Kura Oncology, Inc. | $13.06 | +40.28% | +26.37% | +66.16% |
| JANX | Janux Therapeutics, Inc. | $18.89 | +25.93% | +38.39% | −19.10% |
| TDOC | Teladoc Health, Inc. | $6.33 | −32.37% | −10.21% | −18.22% |
| SVRA | Savara Inc. | $5.61 | +5.25% | −0.53% | +70.52% |
| LMRI | Lumexa Imaging Holdings, Inc. | $11.96 | +9.02% | −31.85% | −35.42% |
| STAA | STAAR Surgical Company | $22.86 | +0.88% | −3.14% | −16.90% |
| IVA.PA | Inventiva S.A. | 4.09 EUR | +3.94% | +0.99% | −14.63% |
| RHK.DE | RHÖN-KLINIKUM Aktiengesellschaft | 14.70 EUR | +13.08% | +15.81% | +24.49% |
| IVA | Inventiva S.A. | $4.82 | +3.88% | +1.26% | −7.84% |
| 2160.T | GNI Group Ltd. | 2,879.00 JPY | +25.17% | +25.72% | +8.36% |
| TTALO.HE | Terveystalo Oyj | 7.78 EUR | +4.29% | −16.20% | −22.31% |
| T2DH34.SA | Teladoc Health, Inc. | 32.09 BRL | −32.46% | −15.77% | −24.67% |
| SPH.WA | Sopharma AD | 7.76 PLN | +8.08% | −39.14% | −38.71% |
| IRMD | IRADIMED CORPORATION | $87.47 | −7.76% | −8.02% | +19.80% |
| OPK | OPKO Health, Inc. | $1.51 | −8.48% | +18.90% | +6.34% |
| 7476.T | AS ONE Corporation | 2,473.00 JPY | −4.18% | +4.62% | +2.31% |
| PHIL.MI | Philogen S.p.A. | 23.85 EUR | +1.06% | +6.10% | +4.75% |
| AVTX | Avalo Therapeutics, Inc. | $20.55 | +5.28% | +20.74% | +112.95% |
| J2AZ34.SA | Jazz Pharmaceuticals plc | 88.80 BRL | −0.54% | +35.66% | +35.66% |
| 4547.T | Kissei Pharmaceutical Co., Ltd. | 4,095.00 JPY | −5.54% | −9.37% | −1.28% |
| 006280.KS | GC Biopharma Corp. | 127,100.00 KRW | +12.28% | −19.46% | −2.60% |
| SLDB | Solid Biosciences Inc. | $9.72 | +21.96% | +78.35% | +72.95% |
| LXRX | Lexicon Pharmaceuticals, Inc. | $2.31 | −1.28% | +102.63% | +104.42% |
| CSTL | Castle Biosciences, Inc. | $34.08 | +42.65% | −11.57% | +52.96% |
| 069620.KS | Daewoong Pharmaceutical Co., Ltd | 124,000.00 KRW | +1.56% | −25.30% | −9.51% |
| WVE | Wave Life Sciences, Inc. | $5.23 | −11.21% | −67.21% | −48.12% |
| ABUS | Arbutus Biopharma Corporation | $5.19 | +17.69% | +8.81% | +42.19% |
| GUBRA.CO | Gubra A/S | 402.40 DKK | +6.23% | −24.64% | +4.79% |
| GXI.DE | Gerresheimer AG | 25.58 EUR | −9.23% | −7.99% | −39.73% |
| QDEL | QuidelOrtho Corporation | $14.91 | −10.56% | −48.19% | −46.31% |
| MEDCL.PA | MedinCell S.A. | 24.58 EUR | −6.18% | −0.57% | +41.92% |
| PCRX | Pacira BioSciences, Inc. | $25.90 | −3.39% | +5.89% | −0.88% |
| CADL | Candel Therapeutics, Inc. | $13.28 | +37.19% | +144.12% | +124.70% |
| IMMX | Immix Biopharma, Inc. | $14.07 | +66.71% | +159.12% | +617.86% |
| GERN | Geron Corporation | $1.53 | +5.52% | +15.91% | +8.51% |
| HELP | Cybin D/B/A Helus Pharma | $13.63 | +79.34% | +64.61% | +77.71% |
| 7730.T | Mani, Inc. | 1,607.00 JPY | +5.38% | +10.38% | +29.48% |
| ARDX | Ardelyx, Inc. | $3.83 | −24.68% | −37.72% | −38.13% |
| DSGN | Design Therapeutics, Inc. | $15.59 | +31.34% | +71.32% | +194.71% |
| VETO.PA | Vetoquinol SA | 70.60 EUR | −3.29% | −16.35% | −6.37% |
| BVS | Bioventus Inc. | $13.97 | +5.75% | +93.76% | +86.52% |
| EUZ.DE | Eckert & Ziegler SE | 13.18 EUR | −4.56% | −12.19% | −24.60% |
| 4521.T | Kaken Pharmaceutical Co., Ltd. | 3,995.00 JPY | +0.13% | +1.77% | +10.07% |
| OLMA | Olema Pharmaceuticals, Inc. | $10.85 | −6.63% | −57.08% | +89.02% |
| NEU.WA | NEUCA S.A. | 758.00 PLN | +1.34% | −9.22% | +15.02% |
| ANNX | Annexon, Inc. | $4.99 | +0.40% | +6.40% | +136.49% |
| DBVT | DBV Technologies S.A. | $14.52 | +7.56% | −23.78% | +53.00% |
| AMPH | Amphastar Pharmaceuticals, Inc. | $22.02 | +9.28% | −16.78% | −27.78% |
| XVIVO.ST | Xvivo Perfusion AB (publ) | 278.80 SEK | +9.08% | +53.95% | +59.31% |
| CLYM | Climb Bio Inc | $16.08 | +30.84% | +328.80% | +603.72% |
| PHN.MI | Pharmanutra S.p.A. | 81.50 EUR | −1.81% | +53.54% | +70.46% |
| 3046.T | JINS HOLDINGS Inc. | 6,230.00 JPY | −9.58% | +14.30% | −22.48% |
| ACRS | Aclaris Therapeutics, Inc. | $6.19 | +16.14% | +114.93% | +240.11% |
| B2RK34.SA | Bruker Corporation | 30.63 BRL | −0.49% | +63.27% | +63.27% |
| DBV.PA | DBV Technologies S.A. | 2.53 EUR | +5.42% | −22.51% | +60.13% |
| CBLL | CeriBell, Inc. | $23.45 | +31.52% | +10.09% | +102.16% |
| 4587.T | PeptiDream Inc. | 1,107.50 JPY | +16.74% | −31.68% | −27.31% |
| SGP | SpyGlass Pharma, Inc. | $26.64 | +23.22% | +0.91% | +0.91% |
| ANL | Adlai Nortye Ltd. | $15.06 | +18.68% | +991.30% | +791.12% |
| TBPH | Theravance Biopharma, Inc. | $17.03 | +0.83% | −6.17% | +23.41% |
| SYNSAM.ST | Synsam AB (publ) | 59.50 SEK | +5.50% | −7.98% | +5.66% |
| 7780.T | Menicon Co., Ltd. | 1,884.00 JPY | +4.09% | +21.53% | +54.36% |
| TALK | Talkspace, Inc. | $5.25 | +0.77% | +49.57% | +93.73% |
| BBNX | Beta Bionics, Inc. | $19.34 | +22.41% | −33.88% | +1.95% |
| AVR | Anteris Technologies Global Corp. | $8.95 | +9.55% | +81.91% | +144.54% |
| RIGL | Rigel Pharmaceuticals, Inc. | $46.48 | +20.73% | +11.12% | +16.99% |
| INMD | InMode Ltd. | $14.93 | −3.49% | +0.88% | −1.71% |
| MCAP.ST | MedCap AB (publ) | 554.50 SEK | +3.64% | +4.03% | −10.28% |
| SIBN | SI-BONE, Inc. | $19.43 | +8.37% | −1.82% | +17.12% |
| AVR.AX | Anteris Technologies Global Corp. | 12.28 AUD | +3.63% | +64.83% | +106.39% |
| FDMT | 4D Molecular Therapeutics, Inc. | $15.56 | +57.97% | +112.57% | +140.87% |
| COLL | Collegium Pharmaceutical, Inc. | $27.51 | −23.37% | −39.58% | −29.08% |
| 4694.T | BML, Inc. | 3,625.00 JPY | −2.03% | −3.47% | +5.42% |
| ACHV | Achieve Life Sciences, Inc. | $8.27 | +33.82% | +66.40% | +177.52% |
| DYVOX.ST | Dynavox Group AB (publ) | 76.70 SEK | +4.14% | −21.71% | −39.29% |
| AHG | Akso Health Group | $0.99 | −32.19% | −38.12% | −43.10% |
| OXB.L | Oxford Biomedica plc | 515.00 GBP | −5.68% | −21.37% | −9.81% |
| PHAR | Pharming Group N.V. | $11.95 | −7.08% | −30.28% | −14.47% |
| SLN | Silence Therapeutics plc | $13.53 | +17.14% | +120.00% | +160.19% |
| HSTM | HealthStream, Inc. | $28.76 | −0.31% | +26.59% | +1.86% |
| SFL.MI | Safilo Group S.p.A. | 1.85 EUR | +14.02% | −5.33% | +20.65% |
| AMS.L | Advanced Medical Solutions Group plc | 281.50 GBP | +0.36% | +29.14% | +38.01% |
| GNFT.PA | Genfit S.A. | 14.30 EUR | +5.30% | +172.38% | +310.45% |
| APOTEA.ST | Apotea AB (publ) | 75.30 SEK | +1.41% | −16.05% | −26.38% |
| ESPR | Esperion Therapeutics, Inc. Common Stock | $3.18 | 0.00% | −14.29% | +45.87% |
| NVCT | Nuvectis Pharma, Inc. | $25.00 | +26.14% | +193.77% | +275.94% |
| EIQ.AX | Echo IQ Limited | 1.53 AUD | +21.03% | +498.04% | +609.30% |
| WELL.TO | WELL Health Technologies Corp. | 4.38 CAD | +9.23% | +8.15% | −8.18% |
| ARJO-B.ST | Arjo AB (publ) | 28.38 SEK | +4.11% | −6.88% | −15.25% |
| AURA | Aura Biosciences, Inc. | $7.73 | +9.65% | +45.85% | +20.03% |
| UU8.F | Neurogene Inc. | 33.20 EUR | +21.17% | +29.18% | +165.60% |
| STTK | Shattuck Labs, Inc. | $7.90 | +15.84% | +112.94% | +690.00% |
| VREX | Varex Imaging Corporation | $18.48 | +66.04% | +58.63% | +61.40% |
| SNT.WA | Synektik Spólka Akcyjna | 338.40 PLN | −5.58% | +21.82% | +53.07% |
| AHCO | AdaptHealth Corp. | $5.67 | −49.47% | −41.37% | −38.44% |
| NGNE | Neurogene Inc. | $38.41 | +15.62% | +90.53% | +95.02% |
| 001067.KS | JW Pharmaceutical Corporation | 46,100.00 KRW | +5.73% | −21.21% | −23.16% |
| MNPR | Monopar Therapeutics Inc. | $113.72 | +4.24% | +72.28% | +226.69% |
| 4588.T | Oncolys BioPharma Inc. | 4,080.00 JPY | +66.46% | +173.09% | +539.50% |
| DRUG | Bright Minds Biosciences Inc. | $76.63 | +6.49% | −8.18% | +76.73% |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | $9.26 | +7.80% | −24.65% | −0.43% |
| D2OC34.SA | Doximity, Inc. | 21.20 BRL | +16.10% | −48.15% | −65.76% |
| 4534.T | Mochida Pharmaceutical Co., Ltd. | 3,290.00 JPY | +1.39% | −6.04% | +7.74% |
| SOPH | SOPHiA GENETICS SA | $8.53 | +53.14% | +82.66% | +156.16% |
| CTMX | CytomX Therapeutics, Inc. | $3.32 | +3.11% | −21.88% | +60.39% |
| ASMB | Assembly Biosciences, Inc. | $35.42 | +38.52% | +4.95% | +36.81% |
| OCS | Oculis Holding AG | $12.97 | +17.32% | −35.15% | −25.14% |
| PHR | Phreesia, Inc. | $11.60 | +6.81% | −28.83% | −63.74% |
| SSII | SS Innovations International, Inc. | $3.57 | −9.16% | −36.81% | −50.55% |
| DHT-UN.TO | DRI Healthcare Trust | 17.63 CAD | −0.51% | +10.64% | +27.29% |
| XOMA | XOMA Royalty Corp | $40.17 | 0.00% | +43.52% | +19.27% |
| PHAT | Phathom Pharmaceuticals, Inc. | $8.77 | −24.79% | −44.18% | −29.50% |
| IRWD | Ironwood Pharmaceuticals, Inc. | $4.29 | +12.89% | +0.47% | +240.48% |
| 9267.T | Genky DrugStores Co., Ltd. | 3,660.00 JPY | −11.91% | −25.91% | −20.07% |
| GYRE | Gyre Therapeutics, Inc. | $6.65 | +11.02% | −2.35% | −18.00% |
| ALLO | Allogene Therapeutics, Inc. | $2.04 | +22.89% | +51.11% | +75.86% |
| C2RS34.SA | CRISPR Therapeutics AG | 36.81 BRL | +20.41% | +2.36% | +0.85% |
| AGMB | AgomAb Therapeutics NV | $14.28 | +13.88% | −2.53% | −2.53% |
| TECX | Tectonic Therapeutic, Inc. | $35.97 | +20.70% | +72.02% | +35.43% |
| OABI | OmniAb, Inc. | $4.81 | +144.16% | +155.85% | +198.76% |
| ZVRA | Zevra Therapeutics, Inc. | $11.74 | +20.66% | +40.77% | +25.43% |
| EVT.DE | Evotec SE | 3.25 EUR | −6.22% | −41.07% | −45.75% |
| 7575.T | Japan Lifeline Co., Ltd. | 1,565.00 JPY | +7.93% | +0.59% | +12.02% |
| BHVN34.SA | BIOHAVEN LTDDRN | 23.68 BRL | 0.00% | −1.09% | −18.03% |
| PROK | ProKidney Corp. | $1.74 | +12.99% | −21.97% | −30.12% |
| EVO | Evotec SE | $1.95 | −0.51% | −38.68% | −44.13% |
| GMRS | GMR Solutions Inc. | $12.82 | −1.38% | −8.30% | −8.30% |
| GUD.TO | Knight Therapeutics Inc. | 9.76 CAD | −0.81% | +65.14% | +50.39% |
| DHT-U.TO | DRI Healthcare Trust | $12.56 | +0.88% | +6.68% | +27.68% |
| EIKN | Eikon Therapeutics, Inc. | $11.98 | +26.24% | −20.13% | −20.13% |
| AQST | Aquestive Therapeutics, Inc. | $5.39 | +43.35% | −16.43% | +40.00% |
| SGMT | Sagimet Biosciences Inc. | $10.86 | +49.38% | +81.30% | +39.59% |
| CBIO | Crescent Biopharma, Inc. | $18.02 | +9.61% | +62.64% | +26.46% |
| LBIRD.PA | Lumibird SA | 25.80 EUR | −1.53% | +23.06% | +57.43% |
| 2HQ0.DE | Tilray Brands, Inc. | 4.07 EUR | +21.13% | −48.80% | −67.56% |
| CRMD | CorMedix Inc. | $8.39 | +14.15% | −31.00% | −40.66% |
| PRME | Prime Medicine, Inc. | $3.58 | +15.86% | +1.42% | +4.37% |
| ANGO | AngioDynamics, Inc. | $15.69 | +9.41% | +23.74% | +56.74% |
| 4565.T | Nxera Pharma Co., Ltd. | 1,109.00 JPY | +27.47% | +31.40% | +22.68% |
| MDXG | MiMedx Group, Inc. | $4.42 | +1.38% | −31.79% | −38.35% |
| VSTM | Verastem, Inc. | $7.39 | +18.62% | +2.21% | −20.45% |
| TLRY.TO | Tilray Brands, Inc. | 6.46 CAD | +13.73% | −51.61% | +240.00% |
| CTNM | Contineum Therapeutics, Inc. | $17.02 | +20.20% | +49.43% | +70.03% |
| KIDS | OrthoPediatrics Corp. | $24.03 | +21.12% | +36.85% | +11.10% |
| IDX.AX | Integral Diagnostics Limited | 2.30 AUD | +10.05% | −7.10% | −19.60% |
| 185750.KS | Chong Kun Dang Pharmaceutical Corp. | 67,050.00 KRW | +2.21% | −19.02% | −16.94% |
| TLRY | Tilray Brands, Inc. | $4.64 | +15.14% | −52.26% | −66.13% |
| CTEV | Claritev Corporation | $37.57 | +65.73% | +10.86% | −47.71% |
| 6197.T | Solasto Corporation | 1,118.00 JPY | +0.63% | +30.15% | +136.68% |
| VALN | Valneva SE | $6.70 | +32.31% | −25.24% | −23.49% |
| DASA3.SA | Diagnósticos da América S.A. | 2.61 BRL | −1.51% | −41.74% | +93.33% |
| CU6.AX | Clarity Pharmaceuticals Ltd | 2.37 AUD | +13.16% | −36.25% | −25.63% |
| VLA.PA | Valneva SE | 2.89 EUR | +31.25% | −23.68% | −24.48% |
| ICLR34.SA | ICON PLC DRN | 41.72 BRL | −2.07% | −17.97% | −14.33% |
| AUTL | Autolus Therapeutics plc | $2.33 | +60.69% | +24.60% | +48.41% |
| AYJ.DE | Valneva SE | 2.98 EUR | +35.29% | −23.93% | −21.89% |
| ARVN | Arvinas, Inc. | $9.32 | +13.66% | −18.74% | +15.35% |
| ALT | Altimmune, Inc. | $3.15 | +5.35% | −10.26% | −14.17% |
| MPLT | MapLight Therapeutics, Inc. | $12.86 | +4.47% | −23.32% | −29.88% |
| CTKB | Cytek Biosciences, Inc. | $4.57 | +2.47% | −7.11% | +11.74% |
| 3034.T | Qol Holdings Co., Ltd. | 2,497.00 JPY | +12.88% | +21.60% | +24.35% |
| RGNX | REGENXBIO Inc. | $9.38 | −2.29% | −30.88% | +6.35% |
| CRW.L | Craneware plc | 1,272.00 GBP | +2.75% | −33.40% | −40.83% |
| EQS.PA | Equasens Société anonyme | 34.05 EUR | −1.02% | −24.08% | −25.98% |
| WEAV | Weave Communications, Inc. | $7.31 | +6.10% | +1.95% | −5.68% |
| EOLS | Evolus, Inc. | $8.78 | +41.16% | +30.65% | +15.83% |
| NAN.AX | Nanosonics Limited | 2.71 AUD | −13.69% | −30.87% | −39.91% |
| ARTV | Artiva Biotherapeutics, Inc. | $11.77 | +11.78% | +178.25% | +259.94% |
| BWAY | BrainsWay Ltd. | $14.30 | −7.68% | +48.26% | +87.42% |
| 4559.T | Zeria Pharmaceutical Co., Ltd. | 2,062.00 JPY | −5.72% | −0.79% | +3.91% |
| ZURA | Zura Bio Limited | $5.99 | +8.12% | +7.93% | +177.31% |
| DCTH | Delcath Systems, Inc. | $16.40 | +41.99% | +64.82% | +49.91% |
| SPRY | ARS Pharmaceuticals, Inc. | $6.03 | +6.35% | −47.52% | −55.13% |
| RAY-B.ST | RaySearch Laboratories AB (publ) | 181.70 SEK | +3.06% | −15.47% | −29.98% |
| OVID | Ovid Therapeutics Inc. | $2.88 | +22.03% | +63.64% | +128.57% |
| EVH | Evolent Health, Inc. | $4.92 | +31.55% | +26.48% | −48.86% |
| ENTX | Entera Bio Ltd. | $3.19 | −2.15% | +80.23% | +62.76% |
| CERS | Cerus Corporation | $2.74 | −6.16% | +39.09% | +109.16% |
| 005257.KS | GC Corp. | 16,630.00 KRW | +20.51% | −35.95% | −40.16% |
| 003850.KS | Boryung Corporation | 8,940.00 KRW | +18.10% | −4.39% | +9.00% |
| KYTX | Kyverna Therapeutics, Inc. | $8.61 | +14.95% | −1.82% | +133.33% |
| CABA | Cabaletta Bio, Inc. | $3.25 | +19.05% | +47.06% | +116.67% |
| FLGT | Fulgent Genetics, Inc. | $19.81 | +0.92% | −22.59% | −8.46% |
| SRTA | Strata Critical Medical, Inc. | $6.12 | +20.24% | +24.14% | +33.62% |
| AYA.AX | Artrya Limited | 5.03 AUD | +5.45% | −0.79% | +157.95% |
| TCMD | Tactile Systems Technology, Inc. | $23.51 | −15.25% | −14.20% | +78.78% |
| 2664.T | Cawachi Limited | 3,760.00 JPY | +8.20% | +28.43% | +38.25% |
| 137310.KS | SD Biosensor, Inc. | 6,140.00 KRW | +1.66% | −30.67% | −38.35% |
| 003090.KS | Daewoong Co., Ltd. | 17,280.00 KRW | +8.27% | −19.25% | −27.35% |
| BOI.PA | Boiron SA | 25.80 EUR | −5.84% | −14.29% | +21.99% |
| PRLD | Prelude Therapeutics Incorporated | $6.56 | +41.38% | +140.29% | +412.50% |
| CCCC | C4 Therapeutics, Inc. | $4.24 | +19.44% | +119.69% | +64.34% |
| 019175.KS | Shinpoong Pharmaceutical Co.,Ltd | 13,370.00 KRW | +23.80% | −43.35% | −40.58% |
| 7979.T | Shofu Inc. | 2,321.00 JPY | +6.76% | +30.43% | +21.34% |
| 4480.T | Medley, Inc. | 2,713.00 JPY | +30.12% | +15.94% | +9.22% |
| TOI | Starling Oncology Inc | $6.20 | +25.25% | +68.94% | +79.19% |
| MEDI.OL | Medistim ASA | 263.00 NOK | +16.37% | +4.43% | +4.43% |
| DNA | Ginkgo Bioworks Holdings, Inc. | $7.23 | −6.10% | −16.90% | −41.46% |
| NPCE | NeuroPace, Inc. | $14.68 | −4.11% | −3.23% | +65.32% |
| 3151.T | Vital KSK Holdings, Inc. | 1,670.00 JPY | −2.51% | +21.29% | +40.44% |
| EVMN | Evommune, Inc. | $14.11 | +25.42% | −18.49% | −30.25% |
| CLPT | ClearPoint Neuro, Inc. | $16.37 | +12.66% | +16.68% | +53.85% |
| IMR.AX | Imricor Medical Systems, Inc. | 1.95 AUD | +0.78% | +18.96% | +40.43% |
| J8J.F | TransThera Sciences (Nanjing), Inc. | 1.04 EUR | +0.97% | −90.91% | −90.91% |
| 4592.T | SanBio Company Limited | 997.00 JPY | +10.78% | −39.10% | −57.08% |
| REG1V.HE | Revenio Group Oyj | 14.78 EUR | +16.56% | −33.12% | −38.54% |
| SENS | Senseonics Holdings, Inc. | $9.34 | +90.22% | +58.57% | +0.43% |
| ALVIO.PA | Valerio Therapeutics Société anonyme | 0.81 EUR | +8.00% | +386.49% | +1198.08% |
| CGC | Canopy Growth Corporation | $1.04 | +15.77% | −13.03% | −31.46% |
| EPRX | Eupraxia Pharmaceuticals Inc. | $7.43 | +21.80% | −1.85% | +40.72% |
| WEED.TO | Canopy Growth Corporation | 1.43 CAD | +13.49% | −12.80% | −31.25% |
| EDIT | Editas Medicine, Inc. | $3.18 | +21.37% | +55.12% | +19.10% |
| EPRX.TO | Eupraxia Pharmaceuticals Inc. | 10.28 CAD | +20.23% | −1.72% | +43.78% |
| NRC | NRC Health | $22.00 | −1.52% | +23.14% | +45.92% |
| 4549.T | Eiken Chemical Co., Ltd. | 2,296.00 JPY | −8.71% | −3.54% | −5.16% |
| RLMD | Relmada Therapeutics, Inc. | $4.55 | −13.00% | +4.12% | +579.10% |
| RZLT | Rezolute, Inc. | $5.04 | +2.44% | +132.79% | −30.00% |
| PNV.AX | PolyNovo Limited | 1.03 AUD | +17.05% | −17.60% | −23.99% |
| PACB | Pacific Biosciences of California, Inc. | $1.56 | +12.23% | −15.22% | +17.29% |
| KMDA | Kamada Ltd. Ordinary Shares | $8.38 | +18.70% | +22.82% | +21.09% |
| 317450.KS | MYUNGIN PHARM | 45,750.00 KRW | +14.09% | −25.73% | −55.96% |
| CAPR | Capricor Therapeutics, Inc. | $9.36 | +42.47% | −66.94% | +49.76% |
| AGY.L | Allergy Therapeutics plc | 5.60 GBP | −5.08% | −52.94% | −30.00% |
| PGMN3.SA | Empreendimentos Pague Menos S.A. | 3.45 BRL | +8.15% | −44.80% | −1.57% |
| QTTB | Q32 Bio Inc. | $16.18 | +2.99% | +370.35% | +840.70% |
| OCGN | Ocugen, Inc. | $1.41 | +13.71% | +2.17% | +35.58% |
| PRTA | Prothena Corporation plc | $9.25 | +8.06% | +0.54% | +8.06% |
| 005690.KS | Pharmicell Co., Ltd. | 10,850.00 KRW | +20.82% | −24.76% | −0.03% |
| PBYI | Puma Biotechnology, Inc. | $9.16 | +14.93% | +58.75% | +79.61% |
| CVX.PA | Carvolix SA | 7.18 EUR | +17.70% | +293.42% | +293.42% |
| SGHT | Sight Sciences, Inc. | $8.37 | +57.92% | +11.90% | +97.87% |
| 001060.KS | JW Pharmaceutical Corporation | 26,850.00 KRW | +22.05% | +6.29% | +26.96% |
| KSI.TO | kneat.com, inc. | 6.50 CAD | +0.46% | +30.52% | +19.93% |
| BIOA | BioAge Labs, Inc. | $9.84 | −55.11% | −23.30% | +107.59% |
| HNSA.ST | Hansa Biopharma AB (publ) | 43.30 SEK | +19.22% | +32.42% | +35.65% |
| ARCT | Arcturus Therapeutics Holdings Inc. | $15.83 | +175.30% | +153.28% | −8.44% |
| MCTA | Charming Medical Limited | $29.36 | 0.00% | 0.00% | +319.36% |
| BNTC | Benitec Biopharma Inc. | $12.88 | +8.33% | +2.34% | +0.16% |
| AVIR | Atea Pharmaceuticals, Inc. | $5.51 | +22.17% | +58.33% | +53.06% |
| CARL | Carlsmed, Inc. | $16.18 | +31.44% | +39.12% | +16.40% |
| AVCT.L | Avacta Group Plc | 69.50 GBP | +0.72% | +20.87% | +26.36% |
| CMPX | Compass Therapeutics, Inc. | $2.43 | +19.12% | −53.00% | −25.91% |
| 001065.KS | JW Pharmaceutical Corporation | 22,800.00 KRW | +8.83% | −18.20% | −19.05% |
| LRMR | Larimar Therapeutics, Inc. | $4.17 | +8.88% | +20.17% | +6.92% |
| EYPT | EyePoint, Inc. | $4.99 | −58.28% | −71.45% | −57.85% |
| FRX.TO | Fennec Pharmaceuticals Inc. | 17.00 CAD | +21.86% | +63.30% | +36.00% |
| MASS | 908 Devices Inc. | $10.37 | +47.51% | +103.73% | +64.60% |
| CCRN | Cross Country Healthcare Inc | $13.25 | 0.00% | +64.39% | +0.38% |
| FENC | Fennec Pharmaceuticals Inc. | $12.17 | +22.43% | +58.46% | +34.62% |
| 000640.KS | Dong-A Socio Holdings Co., Ltd. | 91,600.00 KRW | +8.02% | −11.55% | −15.77% |
| 4569.T | KYORIN Pharmaceutical Co., Ltd. | 1,171.00 JPY | −3.86% | −23.00% | −19.86% |
| LXEO | Lexeo Therapeutics, Inc. | $5.01 | +14.12% | −47.87% | +3.30% |
| GALT | Galectin Therapeutics Inc. | $4.15 | +22.42% | +2.47% | +4.27% |
| XFOR | X4 Pharmaceuticals, Inc. | $4.17 | +6.11% | +7.20% | −1.42% |
| ENTA | Enanta Pharmaceuticals, Inc. | $14.15 | +12.21% | −1.87% | +65.89% |
| CEVI.ST | CellaVision AB (publ) | 164.00 SEK | +7.47% | +10.88% | −5.28% |
| FYB.DE | Formycon AG | 18.44 EUR | −2.64% | −29.35% | −25.04% |
| BLAU3.SA | Blau Farmacêutica S.A. | 9.07 BRL | +4.13% | −34.30% | −2.28% |
| 4552.T | JCR Pharmaceuticals Co., Ltd. | 531.00 JPY | +2.71% | −21.85% | −9.63% |
| LNA.PA | LNA Santé SA | 33.90 EUR | −2.87% | +38.37% | +11.88% |
| M12.DE | M1 Kliniken AG | 18.36 EUR | −2.86% | +1.10% | +37.84% |
| RCKT | Rocket Pharmaceuticals, Inc. | $3.66 | +16.56% | +5.78% | +10.24% |
| PRTC.L | PureTech Health plc | 121.20 GBP | +0.17% | −2.73% | −4.27% |
| 5889.T | JAPAN EYEWEAR HOLDINGS CO LTD | 2,623.00 JPY | +5.13% | +30.89% | +27.04% |
| FHTX | Foghorn Therapeutics Inc. | $6.69 | +30.41% | +28.90% | +23.66% |
| OFIX | Orthofix Medical Inc. | $9.75 | −20.47% | −34.30% | −34.30% |
| TBRG | TruBridge Inc | $26.24 | 0.00% | +25.55% | +30.42% |
| IPSC | Century Therapeutics, Inc. | $2.14 | +4.39% | +115.08% | +315.53% |
| NIOX.L | NIOX Group Plc | 66.60 GBP | +8.82% | −2.03% | −9.49% |
| UPB | Upstream Bio, Inc. | $7.13 | +11.41% | −73.66% | −57.31% |
| EGTX.ST | Egetis Therapeutics AB (publ) | 7.87 SEK | +25.72% | +52.22% | +51.35% |
| TKNO | Alpha Teknova, Inc. | $7.22 | +41.85% | +85.13% | +62.25% |
| E2NO34.SA | Enovis Corporation | 34.59 BRL | +7.86% | +12.74% | −19.24% |
| MOBI | Mobia Medical, Inc. | $11.65 | +8.68% | −0.85% | −0.85% |
| AUNA | Auna SA | $5.23 | +0.58% | +9.87% | −16.85% |
| CRNA.OL | Circio Holding ASA | 11.92 NOK | +37.80% | +877.05% | +1733.85% |
| ONCO3.SA | Oncoclínicas do Brasil Serviços Médicos S.A. | 1.92 BRL | +214.75% | −29.41% | −33.79% |
| 4886.T | ASKA Pharmaceutical Holdings Co.,Ltd. | 2,138.00 JPY | −3.87% | +5.30% | −10.08% |
| VOX.WA | Voxel S.A. | 134.20 PLN | +6.85% | +10.36% | −18.11% |
| CGS.AX | Cogstate Limited | 3.20 AUD | +22.88% | +39.52% | +85.76% |
| 368A.T | KITAZATO CORPORATION | 1,495.00 JPY | +7.55% | −1.89% | −1.33% |
| ACL.AX | Australian Clinical Labs Limited | 2.81 AUD | +15.64% | +4.75% | +5.46% |
| SLP | Simulations Plus, Inc. | $18.41 | +0.44% | +1.66% | +28.20% |
| AGEN | Agenus Inc. | $8.25 | +25.00% | +155.42% | +81.72% |
| PALI | Palisade Bio, Inc. | $2.13 | +5.45% | −14.80% | +222.73% |
| ZNTL | Zentalis Pharmaceuticals, Inc. | $3.89 | −15.80% | +183.94% | +113.74% |
| 2395.T | Shin Nippon Biomedical Laboratories, Ltd. | 1,403.00 JPY | +5.25% | −11.69% | −13.02% |
| VHI.TO | Vitalhub Corp. | 8.11 CAD | +16.69% | −14.99% | −36.39% |
| LYEL | Lyell Immunopharma, Inc. | $15.49 | +19.25% | −46.55% | +37.32% |
| N3B.F | Anbio Biotechnology | 6.40 EUR | −24.26% | −62.13% | −83.42% |
| DMAC | DiaMedica Therapeutics Inc. | $6.70 | +0.90% | −15.51% | +12.04% |
| CATX | Perspective Therapeutics, Inc. | $3.16 | +10.10% | +13.26% | −12.47% |
| 262A.T | INTERMESTIC INC | 1,857.00 JPY | −1.85% | −3.38% | −28.96% |
| 3733.T | Software Service, Inc. | 12,520.00 JPY | +10.50% | −6.64% | −14.23% |
| IFRX | InflaRx N.V. | $2.42 | +43.20% | +122.02% | +142.00% |
| ALCLS.PA | Cellectis S.A. | 2.94 EUR | +16.59% | −30.30% | +27.74% |
| OPT.L | Optima Health plc | 240.50 GBP | +1.48% | +20.85% | +9.32% |
| STRO | Sutro Biopharma, Inc. | $21.43 | −9.69% | +95.53% | +138.11% |
| VMD | Viemed Healthcare, Inc. | $9.33 | −21.73% | +29.22% | +29.94% |
| SABS | SAB Biotherapeutics, Inc. | $3.88 | +12.46% | +2.92% | +83.02% |
| 219A.T | HEARTSEED INC | 2,435.00 JPY | +48.48% | +34.90% | −30.13% |
| PNVL3.SA | Dimed S.A. Distribuidora de Medicamentos | 12.09 BRL | +4.22% | +1.62% | +20.56% |
| HUM.ST | Humana AB (publ) | 71.70 SEK | +14.72% | +46.12% | +81.84% |
| IKT | Inhibikase Therapeutics, Inc. | $2.49 | +7.79% | +27.69% | +39.11% |
| 377740.KS | BioNote, Inc. | 4,750.00 KRW | +6.86% | −10.21% | −13.05% |
| CLLS | Cellectis S.A. | $3.42 | +20.42% | −28.75% | +28.09% |
| ABEO | Abeona Therapeutics Inc. | $6.01 | −0.17% | +13.18% | −12.90% |
| NNNN | Anbio Biotechnology | $7.72 | −23.94% | −73.81% | −83.55% |
| OCA.AX | Oceania Healthcare Limited | 0.66 AUD | +4.80% | −18.13% | +9.17% |
| 019170.KS | Shinpoong Pharmaceutical Co.,Ltd | 8,810.00 KRW | +21.18% | −36.80% | −30.36% |
| CUV.AX | Clinuvel Pharmaceuticals Limited | 9.36 AUD | −2.40% | −26.36% | −24.94% |
| 197A.T | TAUNS LABORATORIES INC. | 504.00 JPY | +4.56% | −0.59% | −11.13% |
| IMRX | Immuneering Corporation | $5.15 | +21.46% | −22.21% | −0.77% |
| P2OD34.SA | Insulet Corporation | 24.68 BRL | −12.58% | −26.20% | −26.20% |
| PRQR | ProQR Therapeutics N.V. | $2.35 | +33.52% | +18.09% | +6.33% |
| 249420.KS | Ildong Pharmaceutical Co., Ltd. | 14,450.00 KRW | +18.93% | −62.41% | −40.38% |
| 005250.KS | GC Corp. | 10,000.00 KRW | +10.62% | −35.88% | −32.75% |
| RCEL | AVITA Medical, Inc. | $10.59 | +129.72% | +205.19% | +133.77% |
| AVH.AX | AVITA Medical, Inc. | 2.87 AUD | +117.05% | +160.45% | +106.12% |
| ILM1.DE | Medios AG | 10.92 EUR | −1.62% | −25.61% | −26.32% |
| VNDA | Vanda Pharmaceuticals Inc. | $5.35 | +3.68% | −35.15% | +15.80% |
| SBS.DE | Stratec SE | 22.85 EUR | +11.46% | +3.39% | −16.91% |
| MATD3.SA | Hospital Mater Dei S.A. | 5.01 BRL | +1.62% | −2.72% | +11.78% |
| SMTI | Sanara MedTech Inc. | $34.65 | +30.07% | +50.00% | +2.09% |
| NP5.DE | Newron Pharmaceuticals S.p.A. | 13.50 EUR | +8.87% | −48.77% | +47.70% |
| OBIO | Orchestra BioMed Holdings, Inc. | $5.26 | +36.27% | +22.04% | +85.21% |
| IRD | Opus Genetics, Inc. | $3.80 | +11.44% | +79.25% | +216.67% |
| VICO.ST | Vicore Pharma Holding AB (publ) | 10.74 SEK | −0.74% | −2.19% | −1.29% |
| ANCR.L | Animalcare Group PLC | 335.00 GBP | 0.00% | +40.76% | +28.86% |
| RAC.AX | Racura Oncology Ltd | 2.23 AUD | +12.06% | −22.30% | +87.39% |
| RNAC | Cartesian Therapeutics, Inc. | $10.19 | +33.20% | +50.74% | −4.09% |
| YDES | YD Bio Ltd | $4.34 | +88.70% | −63.83% | −63.83% |
| 7779.T | CYBERDYNE Inc. | 232.00 JPY | +5.45% | +20.83% | +12.08% |
| TMCI | Treace Medical Concepts, Inc. | $4.72 | +17.71% | +88.80% | −36.39% |
| EBS | Emergent BioSolutions Inc. | $5.97 | −18.33% | −52.28% | −30.50% |
| FATE | Fate Therapeutics, Inc. Common Stock | $2.57 | +10.78% | +159.60% | +129.46% |
| BCYC | Bicycle Therapeutics plc | $4.36 | +10.53% | −34.81% | −37.79% |
| TLSI | TriSalus Life Sciences, Inc. | $4.93 | +13.86% | −19.18% | −3.33% |
| 4554.T | Fuji Pharma Co., Ltd. | 1,843.00 JPY | −2.85% | −2.52% | +26.29% |
| MED.DE | MEDICLIN Aktiengesellschaft | 5.45 EUR | +31.64% | +51.39% | +75.81% |
| AMRN | Amarin Corporation plc | $14.38 | +3.05% | +4.77% | −7.08% |
| AVXL | Anavex Life Sciences Corp. | $3.24 | +26.07% | −11.96% | −65.71% |
| 4894.T | Cuorips Inc. | 5,720.00 JPY | +35.06% | −8.04% | −15.38% |
| IDHC.L | Integrated Diagnostics Holdings plc | $0.55 | −9.00% | −21.91% | +16.89% |
| MYGN | Myriad Genetics, Inc. | $3.12 | −41.35% | −49.19% | −47.39% |
| TRDA | Entrada Therapeutics, Inc. | $7.00 | +20.07% | −30.35% | +23.24% |
| BDSX | Biodesix, Inc. | $30.60 | +45.51% | +373.68% | +225.53% |
| FULC | Fulcrum Therapeutics, Inc. | $3.86 | +3.76% | −64.65% | −41.78% |
| 003000.KS | Bukwang Pharmaceutical Co., Ltd. | 4,110.00 KRW | +12.14% | +7.31% | +26.14% |
| NMRA | Neumora Therapeutics, Inc. | $1.56 | −7.14% | −6.02% | −11.36% |
| 0120G0.KS | Samyang Biopharm | 54,100.00 KRW | +52.39% | +4.04% | +79.14% |
| TTRX | Turn Therapeutics Inc. | $9.63 | +25.06% | +105.33% | +37.57% |
| CV | CapsoVision, Inc. | $5.82 | −12.08% | −43.16% | +46.97% |
| ANIK | Anika Therapeutics, Inc. | $21.68 | +43.10% | +131.87% | +136.17% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.